29 related articles for article (PubMed ID: 25127870)
1. Structure-activity relationship of halophenols as a new class of protein tyrosine kinase inhibitors.
Feng XE; Zhao WY; Ban SR; Zhao CX; Li QS; Lin WH
Int J Mol Sci; 2011; 12(9):6104-15. PubMed ID: 22016647
[TBL] [Abstract][Full Text] [Related]
2. Polyamide Backbone Modified Cell Targeting and Penetrating Peptides in Cancer Detection and Treatment.
Shah SS; Casanova N; Antuono G; Sabatino D
Front Chem; 2020; 8():218. PubMed ID: 32296681
[TBL] [Abstract][Full Text] [Related]
3. Aza-Amino Acids Disrupt β-Sheet Secondary Structures.
McMechen MA; Willis EL; Gourville PC; Proulx C
Molecules; 2019 May; 24(10):. PubMed ID: 31109055
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of GHRP-6 azapeptide ligands of the CD36 scavenger receptor by solid-phase submonomer azapeptide synthesis.
Sabatino D; Proulx C; Pohankova P; Ong H; Lubell WD
J Am Chem Soc; 2011 Aug; 133(32):12493-506. PubMed ID: 21692501
[TBL] [Abstract][Full Text] [Related]
5. Azapeptide Synthesis Methods for Expanding Side-Chain Diversity for Biomedical Applications.
Chingle R; Proulx C; Lubell WD
Acc Chem Res; 2017 Jul; 50(7):1541-1556. PubMed ID: 28598597
[TBL] [Abstract][Full Text] [Related]
6. New m-calpain substrate-based azapeptide inhibitors.
Bánóczi Z; Tantos Á; Farkas A; Majer Z; Dókus LE; Tompa P; Hudecz F
J Pept Sci; 2013 Jun; 19(6):370-6. PubMed ID: 23613308
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel azapeptide activators of apoptosis mediated by caspase-9 in cancer cells.
Bourguet CB; Boulay PL; Claing A; Lubell WD
Bioorg Med Chem Lett; 2014 Aug; 24(15):3361-5. PubMed ID: 24986663
[TBL] [Abstract][Full Text] [Related]
8. Microwave-assisted solid-phase aza-peptide synthesis: aza scan of a PKB/Akt inhibitor using aza-arginine and aza-proline precursors.
Freeman NS; Tal-Gan Y; Klein S; Levitzki A; Gilon C
J Org Chem; 2011 May; 76(9):3078-85. PubMed ID: 21410283
[TBL] [Abstract][Full Text] [Related]
9. Submonomer synthesis of azapeptide ligands of the Insulin Receptor Tyrosine Kinase domain.
Kurian LA; Silva TA; Sabatino D
Bioorg Med Chem Lett; 2014 Sep; 24(17):4176-80. PubMed ID: 25127870
[TBL] [Abstract][Full Text] [Related]
10. Azapeptides and their therapeutic potential.
Proulx C; Sabatino D; Hopewell R; Spiegel J; García Ramos Y; Lubell WD
Future Med Chem; 2011 Jul; 3(9):1139-64. PubMed ID: 21806378
[TBL] [Abstract][Full Text] [Related]
11. Azapeptides as pharmacological agents.
Zega A
Curr Med Chem; 2005; 12(5):589-97. PubMed ID: 15777214
[TBL] [Abstract][Full Text] [Related]
12. Azapeptides -A History of Synthetic Milestones and Key Examples.
Fan Cheng K; VanPatten S; He M; Al-Abed Y
Curr Med Chem; 2022; 29(42):6336-6358. PubMed ID: 35538801
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
